Investor Directory
ARCH Venture Partners logo

ARCH Venture Partners

Venture fund

Cheque size
$50K to hundreds of millions per company
Based in
Chicago, Illinois
Focus
Pharma & Drug Discovery, Hospital Operations

ARCH began in 1986 as the Argonne Chicago Development Corporation, set up by the University of Chicago and Argonne National Laboratory to turn research into companies, and became an independent venture partnership in 1992. The firm works from Chicago and Seattle and says it has invested as little as $50,000 and as much as hundreds of millions of dollars in a single company. Cofounder Robert Nelsen seeded Illumina and sits on boards including insitro and Xaira Therapeutics. HTS has covered ARCH leading Trase's $107 million seed round for AI agents that handle hospital administrative work such as faxes.

ARCH Venture Partners builds and backs science companies, mostly in biotechnology, often from the very first check.

Notable investments

  • Trase
  • Illumina
  • insitro
  • Xaira Therapeutics

Companies in the directory

The journey

How ARCH Venture Partners got here, step by step.

  1. 1986

    ARCH Development Corporation

    The University of Chicago and Argonne National Laboratory set up ARCH to commercialize research.

  2. 1992

    Independent firm

    ARCH Venture Partners forms as a private venture partnership.

Related on The Signal